Summary

The growing prevalence of cardiovascular disorders, the expanding elderly population, and the increasing acceptance of wearable ECG devices are driving the growth of the Canadian electrocardiograph (ECG) market. Wearable ECG devices are becoming more prevalent as wearable gadgets such as smartwatches and activity trackers gain popularity. These devices can enable continuous monitoring of heart health, which can aid in the early detection of issues. The universal healthcare system in Canada ensures that all Canadians have access to critical healthcare services. This system, which is managed at the provincial level, influences the acceptance and use of medical technology such as ECG machines. While this system ensures that everyone has equal access to healthcare, budgetary limits and administrative processes can have an impact on the acquisition and distribution of new medical technologies. The great geographic expanse of Canada presents logistical obstacles, particularly in distant or rural locations where access to healthcare services and medical equipment is limited. Portable and telemedicine-compatible ECG equipment is especially useful in overcoming geographical boundaries by allowing remote monitoring and consultations, affecting market choices. Medical devices are regulated by Health Canada to ensure their safety, efficacy, and quality. The ECG device certification procedure adheres to worldwide standards, which has an impact on the introduction and uptake of new technology. Furthermore, government financing and reimbursement regulations have a substantial impact on the use of ECG devices in healthcare facilities, impacting market dynamics. Canada has been looking into telehealth programmes to increase healthcare access, particularly in rural areas. These activities overlap with telemedicine and remote monitoring solutions coupled with ECG equipment, providing a niche market for connected and portable ECG technologies.

According to the research report "Canada Electrocardiograph (ECG) Market Overview, 2028," published by Bonafide Research, the Canada Electrocardiograph (ECG) market is expected to add more than USD 100 Million from 2023 to 2028. Although Canada has a publicly funded healthcare system, managing healthcare costs is an ongoing concern. Budgetary constraints influence medical equipment acquisition decisions, especially for ECG devices. Healthcare providers frequently seek cost-effective solutions without sacrificing quality or functionality, impacting market demand for low-cost but effective ECG technologies. Canada promotes collaborative healthcare networks that enable collaboration among many stakeholders, such as government bodies, healthcare providers, research institutes, and industry participants. Through cooperative initiatives and shared resources, these collaborations frequently foster innovation, facilitate clinical studies, and influence the acceptance of new ECG technology. The integration of health information technology systems is a top issue on Canada's healthcare agenda. It is preferable to use ECG equipment that interacts smoothly with electronic health records (EHRs) and health information sharing platforms. ECG machine interoperability and data sharing capabilities match the country's aim to develop a unified healthcare information ecosystem. Patient-centred care strategies are becoming more popular in Canada. ECG devices with a focus on patient comfort, convenience of use, and user-friendly interfaces are gaining popularity. The emphasis on improving patient experience and engagement drives choices for ECG equipment that are convenient and easy to use. Ontario, being the most populated province, frequently sets healthcare trends. Its established healthcare infrastructure and big urban centres encourage the use of innovative medical technologies such as ECG equipment. Hospitals and healthcare facilities in locations such as Toronto and Ottawa are typically at the forefront of obtaining and implementing cutting-edge ECG technologies.

Based on product market is majorly segmented into resting electrocardiograph (ECG), stress electrocardiograph (ECG), holter monitors, event recorders and others. Stress electrocardiograph (ECG) product type is gaining significant traction in Canada Electrocardiograph (ECG) market. Stress ECGs, also known as exercise or treadmill ECGs, provide dynamic cardiac evaluations by capturing the heart's activity during physical exertion. They provide insights into heart function under stress, allowing for a more accurate diagnosis of coronary artery disease, arrhythmias, and other heart problems that may not be visible on resting ECGs. This diagnostic precision is critical for diagnosing cardiac problems, which contributes to the rising demand for stress ECG equipment. Canada's population is ageing, and cardiovascular disease is becoming more common. As the risk of heart disease increases with age, there is a greater emphasis on preventative care and early identification. Stress ECGs are crucial in assessing cardiovascular health, risk classification, and guiding suitable interventions in line with the country's healthcare priorities. The end user segment of the market includes hospitals & clinics, home settings & ambulatory surgical centers (ASCs) and others. In Canada there is significant rising prevalence of home based Electrocardiograph (ECG) treatments. Canada has gradually expanded its telehealth services, allowing for remote monitoring and consultations. Home-based ECG therapies follow this trend, allowing patients to perform ECG examinations in the comfort of their own homes. Telemedicine technologies make it easier to send ECG data to healthcare providers, allowing for more immediate assessments and interventions without the need for in-person visits. Patients with chronic heart problems must be monitored on a continuous basis. Individuals can take an active role in controlling their cardiac health with home-based ECG equipment. Regular monitoring aids in tracking changes in cardiac rhythm, detecting anomalies, and allowing for prompt interventions or modifications in treatment regimens, thus improving illness management.

Considered in this report:
• Geography: Canada
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Canada Electrocardiograph (ECG) market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product:
• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User:
• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents